Guéguen M, Biddison W E, Long E O
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20852.
J Exp Med. 1994 Nov 1;180(5):1989-94. doi: 10.1084/jem.180.5.1989.
An alternative pathway for class I-restricted antigen presentation has been suggested on the basis of peptides bound to HLA-A2 molecules in cells lacking the transporter for antigen presentation (TAP). Most of these peptides were derived from signal sequences for translocation into the endoplasmic reticulum (ER). However, it is not known whether these peptides can be presented to T cells. The hydrophobic nature of an HLA-A2-restricted T cell epitope (M1 58-66) was exploited to test whether it could be presented to T cells when derived from a signal sequence. Replacing the signal sequence of the influenza virus hemagglutinin molecule H3 with an artificial sequence containing that HLA-A2-restricted T cell epitope resulted in efficient translocation of H3 molecules into the ER and transport to the cell surface. This signal sequence-derived epitope was presented to HLA-A2-restricted T cells. Involvement of cytosolic processing for this presentation is very unlikely, because (a) presentation occurred in cells lacking TAP; (b) expression of H3 molecules with the artificial signal sequence did not produce a detectable cytosolic form of H3; and (c) presentation of the same epitope expressed in cytosolic forms of antigen required TAP. Thus, a peptide derived from a signal sequence cleaved in the ER can provide an epitope for HLA-A2-restricted T cell recognition.
基于在缺乏抗原呈递转运体(TAP)的细胞中与HLA - A2分子结合的肽段,有人提出了一种I类限制性抗原呈递的替代途径。这些肽段大多来源于转运至内质网(ER)的信号序列。然而,尚不清楚这些肽段是否能呈递给T细胞。利用一种HLA - A2限制性T细胞表位(M1 58 - 66)的疏水性来测试当它来源于信号序列时是否能呈递给T细胞。用包含该HLA - A2限制性T细胞表位的人工序列替换流感病毒血凝素分子H3的信号序列,导致H3分子有效转运至内质网并运输到细胞表面。这个来源于信号序列的表位呈递给了HLA - A2限制性T细胞。这种呈递极不可能涉及胞质加工,原因如下:(a)呈递发生在缺乏TAP的细胞中;(b)带有该人工信号序列的H3分子表达未产生可检测到的胞质形式的H3;(c)以抗原的胞质形式表达的相同表位的呈递需要TAP。因此,在内质网中被切割的信号序列衍生的肽段可为HLA - A2限制性T细胞识别提供表位。